Home
|
Contact
|
Search
|
Site Map
About Us
Technology
Products
R&D
Partners
Investors
Media
Careers
Corporate Profile
Share Information
Financial Information
Press Releases
Event Calendar
Presentations
Shareholder Services
Investor Relations Contact
Crucell's press releases
are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader.
If you are new to RSS, we suggest you read the
Introduction to RSS article.
Dutch
German
2008 |
2007
|
2006
|
2005
|
2004
|
2003
|
2002
|
2001
|
2000
25 Jun 2008
DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6® Cell Line Proteins
16 Jun 2008
DSM and Crucell Announce Record Achievement in PER.C6® Technology
30 May 2008
Crucell 2008 Annual General Meeting of Shareholders
20 May 2008
Crucell Announces Research License Agreement with Bioceros on STAR® Technology
13 May 2008
Crucell Announces First Quarter 2008 Results
13 May 2008
Start of Phase II Clinical Study for Rabies Monoclonal Antibody Combination in the Philippines
06 May 2008
Crucell to Release Q1 2008 Earnings on Tuesday, May 13, 2008
29 Apr 2008
Crucell Announces STAR® Research License Agreement with Toyobo Gene Analysis Co. LTD.
09 Apr 2008
Aeras, Crucell and SATVI Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
08 Apr 2008
Crucell Announces STAR® Research License Agreement with Celltrion, Inc.
03 Apr 2008
Crucell Announces First in Man Study with New Adenovirus Vector
31 Mar 2008
Crucell Announces Start of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US
25 Mar 2008
Crucell Announces STAR® Research License Agreement with Medarex Inc
17 Mar 2008
Crucell and DSM Biologics Announce Additional PER.C6® Licensing Agreement with MorphoSys
12 Mar 2008
Crucell Presents a Compelling Case for Investment at Investor and Analyst Day in London
11 Mar 2008
DSM and Crucell Announce PER.C6® Technology Milestone
03 Mar 2008
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
12 Feb 2008
Crucell Announces Fourth Quarter and Full Year 2007 Results
11 Feb 2008
Crucell Nominates Cees de Jong as Management Board Member
31 Jan 2008
Crucell to Release Q4/FY 2007 Earnings on Tuesday, February 12, 2008
30 Jan 2008
Crucell Nominates Steve Davis as Supervisory Board Member
16 Jan 2008
Crucell Reacts to Recent CEVEC Press Release
14 Jan 2008
Crucell Announces STAR® Technology Research License with Korean-based ISU ABXIS
09 Jan 2008
TRADING UPDATE
03 Jan 2008
Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals against Rabies
Home
Contact Us
Search
Site Map
Served
by
MoveNext
© Crucell 2006 |
Disclaimer